华东医药股份有限公司 关于举办投资者接待日活动的公告

Group 1 - The company, East China Pharmaceutical Co., Ltd., will hold an investor reception day on May 15, 2025, to enhance communication with investors and provide insights into its development strategy, operational results, and financial status [1][10]. - The reception will take place after the annual general meeting, from 15:30 to 17:00, at the company's new building in Hangzhou, Zhejiang Province [1][12]. - Investors must register for the event by May 14, 2025, and present identification documents upon arrival [2][5]. Group 2 - The company will collect questions from investors in advance to ensure a focused discussion during the reception [5]. - Key personnel attending the meeting include the Chairman and General Manager, Vice Presidents, and other senior executives [4]. - The company emphasizes compliance with Shenzhen Stock Exchange regulations, requiring attendees to sign a confidentiality agreement [3]. Group 3 - The annual general meeting will also be held on May 15, 2025, from 14:00 to 15:00, with both on-site and online voting options available [12][24]. - The meeting will review various proposals, including related party transactions, with specific voting procedures outlined for shareholders [19][20]. - Shareholders must register between May 9 and May 13, 2025, to participate in the meeting [21].